(877) 505-4777| info@speakersnetwork.com

Endocrinology, Diabetes & Metabolism

Director, USC Clinical Diabetes Programs
Professor of Medicine
Keck School of Medicine of USC

Treatment of Type 1 Diabetes
Treatment of Type 2 Diabetes
Insulin Resistance
Diagnosis and Pathophysiology of Diabetes
Diabetic Dyslipidemia
Atherosclerosis in Women: Need for Risk Factor Reduction
Pre-Diabetes
Diabetes Prevention
Technology in Diabetes: Meters, Apps, Pumps and Sensors-Present and Future

CA

Chair of Pediatric Endocrinology
Professor of Pediatrics

Puberty
Central Precocious Puberty
Delayed Puberty
Growth Disorders
Thyroid Disorders
Obesity
Diabetes in Children and Adolescents
Counseling Obese Pediatric and Adult Patients about Diet and Exercise

CA

Professor of Preventive Medicine

Obesity Prevention and Management
Obesity and Type 2 Diabetes
Obesity Prevention and Management in Children: The Metabolic Syndrome
Obesity and Cancer
Dietary Sugar and Diabetes / CVD
Dietary Sugar and Health Risk of Obesity, Type 2 Diabetes and Fatty Liver Disease

Excellent Speaker and important topic – Annenberg Center for Health Sciences at Eisenhower
CA

Past Clinical Chief, Division of Endocrinology
Associate Clinical Professor of Endocrinology

How to Use the Newest Diabetes Treatments: The Incretin Concept
Intensive Blood Glucose Control for the Hospitalized Patient: A New Standard or Pie in the Sky?
Oral Agents in GDM
Diabetes Update
Pills for Diabetes: Old Choices, New Data
The Evolution of the Insulin Molecule and Insulin Treatment
What’s New about Preventing Diabetic Complications
Diabetic Ketoacidosis: Update in Concepts and Treatments
What Can Doctors Do about Obesity: Medical and Surgical Options
Diabesity: Combined Causes and Combined Risks
Breakthroughs in Obesity Concepts: Leptin, Ghrelin and PYY for the Treatment of Obesity
Thyroid Update
Hyperthyroidism in Primary Care: Diagnosis and Treatment
Hypothyroidism in Primary Care: Changing Concepts
How to Effectively Screen for Endocrine Disease in Primary Care Practice: From Addison’s to Acromegaly
Surgical Options for Obesity

“Excellent speaker and content…First lecture in 20 years that I had no idea what the subject was about and now I know!” – Northridge Hospital
CA

Chief, Division of Endocrinology, Diabetes and Metabolism
Associate Professor of Medicine
Rutgers New Jersey Medical School

Metabolic Syndrome
Type 1 Diabetes
Type 2 Diabetes
Treating Diabetes in the 21st Century
Managing Cardiovascular Risk in the Diabetes Patient
Adrenal Insufficiency
Diabetic Retinopathy
Managing Endocrine Emergencies

Excellent speakers and very good lecture – St Joseph Regional Medical Center
NJ

Assistant Clinical Professor of Diabetes, Endocriniology & Metabolism
City of Hope National Medical Center

Diabetes Update
Diabetes Mellitus
Lipid Metabolism
Vitamin D Deficiency
Hypothyroidism

CA

Clinical Assistant Professor
Division of Endocrinology, Gerontology, and Metabolism
Stanford University Medical Center

Osteoporosis
Obesity
Outpatient Management of Type 2 Diabetes
New Diabetes Drugs
Management of Inpatient Diabetes
Endocrine Emergencies
Endocrine Incidentalomas
Diabetes Care for the Primary Care Provider
Adrenal Insufficiency
Hypercalcemia
Testosterone Deficiency / Male Hypogonadism
Hypoglycemia
Hyperthyroidism / Hypothyroidism
Diabetes and Cardiovascular Outcomes

CA

Associate Professor of Medicine
Division of Endocrinology
Keck School of Medicine of USC

Fatigue Among Healthcare Providers and Its Impact on Patient Safety
The Benefits of Music Therapy
Reactive Hypoglycemia, Insulin Resistance, and Prediabetes: What Is the Connection?
Physician Burnout: Causes and Prevention
Diabetic Neuropathy: Most Common Microvascular Disease in Diabetic Population
Hypercalcemia and Hypocalcemia
Diabetic Foot: Number One Reason for Hospitalization of Diabetic Patients
Hypomagnesemia: The Most Neglected Electrolyte Imbalance in Medical Practice
Diabetic Complications: Neuropathy and Gastropathy in Diabetes
Hyperkalemia and Diabetes: A “Deadly Combination”
Hypoglycemia
Pre-Diabetes
Insulin Resistance
Metabolic Syndrome
Obesity: A Worker of Insulin Resistance
Stress in Health Care Setting: The Burnout Physician
Stress and Patient Safety: The Impact of Medical Errors
Physician Well-Being: How to Become a “Balanced Physician”
Chocolate: The Perfect Food, What Should We Know about It
Hyporenin Hypoaldosteronism : The Risk of Unrecognized Drug Induced Hyperkalemia
Cushing Syndrome: Diagnosis and Treatment
Hyperaldosteronism: A Common Cause of Hypertension

CA

High-risk Diabetic Patients and Prevention of Cardiovascular Events
Treatment for Diabetic Peripheral Neuropathy
Islet Cell Transplant Program
New Treatment Options for Type 1 and Type 2 Diabetes

Wei Feng, M.D., is a board certified endocrinologist with expertise in many areas such as diabetes, thyroid, pituitary, osteoporosis, PCOS, obesity, lipid disorder, and adrenal disease. She has been a staff physician at the Department of Clinical Diabetes, Endocrinology, and Metabolism at City of Hope since 1998. Born in China, Dr. Feng obtained her medical degree at University of Heidelberg in West Germany in 1987. After completing residency training in internal medicine at University of Memphis in Tennessee, she sought endocrine fellowship training at Cedars Sinai Medical Center. She has diverse clinical experience being hospitalist for a year in 1992 after completing residency training at Memphis Regional Medical Center and a faculty member in the Division of General Internal Medicine at USC between 1995 and 1998. Dr. Feng entered private endocrine practice in year of 2005 in Pasadena while maintaining a part-time position at City of Hope. Now she devotes all her time to the practice of endocrinology at the South Pasadena Cancer Center, which is fully affiliated with the Department of Clinical Diabetes and Endocrinology at the City of Hope. Dr. Feng has been a principal investigator for several clinical trials involving long term studies of intervention for high-risk diabetic patients to prevent cardiovascular events, treatment for diabetic peripheral neuropathy, islet cell transplant program, and new treatment options for type 1 and type 2 diabetes.
CA